BRAZE INC-A (BRZE)
US10576N1028 - Common Stock
BRZE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 275 industry peers in the Software industry. No worries on liquidiy or solvency for BRZE as it has an excellent financial health rating, but there are worries on the profitability. BRZE is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
BRZE had negative earnings in the past year.
BRZE had a positive operating cash flow in the past year.
In the past 5 years BRZE always reported negative net income.
BRZE had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
The Return On Assets of BRZE (-15.93%) is worse than 62.18% of its industry peers.
BRZE has a Return On Equity (-29.09%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.93% | ||
| ROE | -29.09% | ||
| ROIC | N/A |
ROA(3y)-15.71%
ROA(5y)-17.29%
ROE(3y)-25.19%
ROE(5y)-32.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 68.72%, BRZE perfoms like the industry average, outperforming 56.73% of the companies in the same industry.
In the last couple of years the Gross Margin of BRZE has grown nicely.
BRZE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.72% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.56%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BRZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BRZE has more shares outstanding
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 6.04 indicates that BRZE is not in any danger for bankruptcy at the moment.
BRZE has a better Altman-Z score (6.04) than 75.64% of its industry peers.
BRZE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.04 |
ROIC/WACCN/A
WACC9.87%
2.3 Liquidity
A Current Ratio of 2.08 indicates that BRZE has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.08, BRZE is doing good in the industry, outperforming 61.09% of the companies in the same industry.
A Quick Ratio of 2.08 indicates that BRZE has no problem at all paying its short term obligations.
BRZE has a Quick ratio of 2.08. This is in the better half of the industry: BRZE outperforms 61.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.08 | ||
| Quick Ratio | 2.08 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 59.38% over the past year.
BRZE shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.76%.
Measured over the past years, BRZE shows a very strong growth in Revenue. The Revenue has been growing by 46.45% on average per year.
EPS 1Y (TTM)59.38%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q71.43%
Revenue 1Y (TTM)32.76%
Revenue growth 3Y46.45%
Revenue growth 5YN/A
Revenue growth Q2Q32.68%
3.2 Future
The Earnings Per Share is expected to grow by 65.00% on average over the next years. This is a very strong growth
Based on estimates for the next years, BRZE will show a very strong growth in Revenue. The Revenue will grow by 22.61% on average per year.
EPS Next Y64.17%
EPS Next 2Y70.02%
EPS Next 3Y65%
EPS Next 5YN/A
Revenue Next Year23.31%
Revenue Next 2Y22.21%
Revenue Next 3Y22.61%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
BRZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BRZE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BRZE's earnings are expected to grow with 65.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y70.02%
EPS Next 3Y65%
5. Dividend
5.1 Amount
No dividends for BRZE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BRAZE INC-A
NASDAQ:BRZE (4/19/2024, 7:00:02 PM)
After market: 38.5 -0.44 (-1.13%)38.94
-0.31 (-0.79%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.89B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.93% | ||
| ROE | -29.09% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.72% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.08 | ||
| Quick Ratio | 2.08 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)59.38%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y64.17%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)32.76%
Revenue growth 3Y46.45%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y